Products for Research Use Only
RegisterLogin

JAK-IN-18

CAT: 0804-HY-144058Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-144058Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JAK-IN-18 is a potent inhibitor of JAK. JAK-IN-18 is useful for the research of multiple diseases, particularly ocular, skin, and respiratory diseases (extracted from patent WO2018204238A1, compound 1) [1].
CAS Number
2247925-32-0
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak-in-18.html
Solubility
10 mM in DMSO
Smiles
FC1=CC(C2=CC(F)=C(O)C=C2CC)=CC3=C1C(C(N4)=NC5=C4CN(C(CN6CCOCC6)=O)CC5)=NN3
Molecular Formula
C27H28F2N6O3
Molecular Weight
522.55
References & Citations
[1]Paul R. Fatheree, et al. Fused imidazo-piperidine jak inhibitor compound. Patent WO2018204238A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-151262-01JAK-IN-23
HY-157011JAK-IN-33
HY-111471JAK-IN-5
HY-18301-01JAK-IN-35
HY-111749JAK-IN-4
HY-144057JAK-IN-17
HY-143444-01JAK-IN-20
HY-14986JAK-IN-32
HY-46262JAK-IN-15
HY-153440-01JAK-IN-25

Alternative Products

CatalogName
MBS5806326JAK-IN-18
BA4919-10JAK-IN-14
BA4937-1JAK-IN-30
BA4922-1JAK-IN-24
JDC67353-01JAK-IN-1
T210131-01JAK-IN-37
T12549-01JAK-IN-11
T79222-01JAK-IN-29
T73250-01JAK-IN-17
MBS3844679-01JAK-IN-4

Popular Products